Zobrazeno 1 - 10
of 30
pro vyhledávání: '"modified citrullinated vimentin"'
Autor:
N. V. Bunchuk
Publikováno v:
Klinicist, Vol 16, Iss 3, Pp 25-33 (2023)
A review of data on the possible causes of an increase rheumatoid factor (RF), antibodies against cyclic citrullinated peptide (ACCP) and antibodies to modified citrullinated vimentin (AMCV) in patients without rheumatoid arthritis (RA) is presented.
Externí odkaz:
https://doaj.org/article/3f76da8b69dd4c5bb92a05b041ef8ed3
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). In this study, we aimed to determine the association of autoantibodies with the echocardiograph
Externí odkaz:
https://doaj.org/article/6d0a8d1c123547bbadf8ef75dc92f31b
Autor:
A. A. Starshinova, A. М. Malkova, Yu. S. Zinchenko, N. Yu. Basantsova, M. V. Pavlova, E. N. Belyaeva, S. V. Lapin, A. V. Masing, E. A. Surkova, P. K. Yablonsky
Publikováno v:
Медицинская иммунология, Vol 21, Iss 5, Pp 911-918 (2019)
Tuberculosis is a granulomatous disease caused by Mycobacterium tuberculosis, being characterized by the development of caseous granulomas in various organs, mainly in lungs. M. tuberculosis is known to be a trigger for autoimmune inflammation, due t
Externí odkaz:
https://doaj.org/article/5aa2151760c84cbaa13bba6d307becad
The article presents the study results of the value of Anti-MCV in children with juvenile arthritis, depending on the variant of the disease. An analysis of obtained results reveal that in children with juvenile arthritis, Anti-MCV indicates the like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c68272b07bc52258206495010b0f10
Autor:
Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, A A Novikov, A V Smirnov, M V Cherkasova, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 3, Pp 267-271 (2013)
Objective: to assess an association between the levels of anti-cyclic citrullinated peptide antibodies (anti-CCP), anti-modified citrullinated vimentin antibodies (anti-MCV), rheumatoid factor (RF), and X-ray signs of destructive changes in RAjoints.
Externí odkaz:
https://doaj.org/article/789c8c20cd08499ea0f4d617c718fd11
Autor:
I.S. Lebets, N.O. Panko
Publikováno v:
Zdorovʹe Rebenka, Vol 8, Iss 2.45, Pp 49-53 (2013)
77 children with inflammatory lesions of the joints have been examined in the study. The characteristics of clinical signs and laboratory parameters in patients with arthritis, who have increased antibody titers to cyclic citrullinated peptide (a-CCP
Externí odkaz:
https://doaj.org/article/34eb4ade4dde4f42b43d46c1f7c74f26
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). In this study, we aimed to determine the association of autoantibodies with the echocardiographic parame
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33ad52fa77dc1a5eee4fa7d53f3943f1
http://link.springer.com/article/10.1186/s12872-020-01676-x
http://link.springer.com/article/10.1186/s12872-020-01676-x
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 5, Pp 30-33 (2012)
Objective — to evaluate the relationship between antibody titers against modified citrullinated vimentin (AMCV), IgM rheumatoid factor (RF), interleukin (IL) 4, IL6 and IL8, and their correlation with rheumatoid arthritis (RA) activity indicators,
Externí odkaz:
https://doaj.org/article/5edc18e4c3e04d49a0fa74d0b55cc1d2
Autor:
Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, A A Novikov, M V Cherkasova, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 3, Pp 25-32 (2012)
Objective: to evaluate the impact of tocilizumab (TCZ) therapy on the level of acute-phase indicators, autoantibodies, and immunoglobulins (Ig) G, M, and A after 2, 4, 8, 12, and 24 weeks as compared to the clinical efficacy of TCZ using DAS 28, SDAI
Externí odkaz:
https://doaj.org/article/27a73727a22245abbd62ea9c5f702fbe
Autor:
Elena Nikolayevna Aleksandrova, A S Avdeyeva, G V Lukina, A A Novikov, M V Cherkasova, T V Popkova, O G Lineva, G Kh Kuzikyants, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 1, Pp 14-21 (2012)
Objective: to study the time course of changes in acute-phase parameters and in the levels of autoantibodies, B lymphocytes, immunoglobulin (Ig) classes G, M, and A in patients with rheumatoid arthritis (RA) 2, 8, 16, and 24 weeks after initiation of
Externí odkaz:
https://doaj.org/article/66b9289f01b441368a73fc9023347e6d